Table 1.
General Characteristics of Normotensive, Controlled Hypertensive, and Resistant Hypertensive Patients
| NT (n=50) | CHT (n=50) | RHT (n=50) | P Value | |
|---|---|---|---|---|
| Women, % | 27 (54) | 30 (60) | 28 (56) | .827 |
| Age, y | 61.2±7 | 62.06±8 | 60.8±8 | .744 |
| BMI, kg/m2 | 26.8±2.8 | 27.4±2.6 | 27.01±2.9 | .524 |
| SBP (office), mm Hg | 125.8±6.2 | 126.5±6.8 | 137.7±10.8 | <.001 |
| DBP (office), mm Hg | 71.6±8.2 | 72.5±9.5 | 88.5±14.1 | <.001 |
| SBP (ABPM), mm Hg | 118.2±5.4 | 124.3±5.2 | 132.3±11.4 | .021 |
| DBP (ABPM), mm Hg | 70.8±6.3 | 74.3±8.1 | 83.6±12.1 | .013 |
| ACE inhibitor, % | 34 (68) | 39 (78) | .184 | |
| ARB, % | 16 (32) | 28 (56) | .013 | |
| β‐Blocker, % | 18 (36) | 30 (60) | .014 | |
| CCB, % | 20 (40) | 29 (58) | .191 | |
| α‐Blocker, % | 6 (12) | 13 (26) | .062 | |
| Diuretic, % | 17 (34) | 50 (100) | <.001 | |
| Statin, % | 9 (18) | 7 (14) | .393 |
Abbreviations: ABPM, ambulatory blood pressure measurement; ACE, angiotensin‐converting enzyme; ARB, angiotensin receptor blocker; BMI, body mass index; CCB, calcium channel blocker; CHT, controlled hypertension; DBP, diastolic blood pressure; NT, normotension; RHT, resistant hypertension; SBP, systolic blood pressure. Data are expressed in frequencies (percentages) or mean±standard deviation. Bold values indicate significance.